Table 1.

Anti-Measles immunogenicity (PRNT₉₀ titer).

MVvac2 X 1 a		-(HBsAg)N X 2 b		-(DIII-S, S)P X 1 a		-(DIII-S, S)P X 2 b		-(DIII-S)N X 2 b
Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post
<1:10	1:1280	<1:10	>1:2560	<1:10	1:1066	<1:10	>1:2560	<1:10	>1:2560
<1:10	1:1280	<1:10	>1:2560	<1:10	1:640	<1:10	>1:2560	<1:10	1:1280
<1:10	1:1280	<1:10	>1:2560	<1:10	1:320	<1:10	1:1280	<1:10	1:1066
<1:10	1:640			<1:10	1:240	<1:10	1:1280
<1:10	1:640					<1:10	1:640
						<1:10	1:640
						<1:10	1:640

a Animals were inoculated with a single 10⁵ TCID₅₀ intraperitoneal dose of the indicated virus, MV immunity was assayed 28 days post-immunization; b Animals were inoculated with two 10⁵ TCID₅₀ intraperitoneal doses in a 28 days time interval of the indicated virus, MV immunity was assayed 14 days post booster dose.